CClinicalTrials.gg
CompletedNCT03926650Updated Apr 9, 2021

The Correlation Between the Frontal Electromyography Parameter in Patient State Index (PSI) Monitor and Train of Four

An observational study in Muscle Relaxation, sponsored by Erzincan University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-04-09.

Sponsored by Erzincan University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The Train Of Four (TOF) Monitor will be placed on ulnar nerve on right wrist of the patients who has surgery under general anaesthesia. This is for stimulation of adductor pollicis muscle. Sedline (Masimo Electromyography(EMG) and Patient State Index(PSI)) Monitor will be placed on the frontal area of head. After the induction of general anaesthesia the investigators will wait for disappearance of eyelash reflex. TOF monitor will be calibrated and muscle relaxant will be applied. After TOF is %0 and disappearance of thumb movement the patient will be intubated. After surgery the investigators will apply muscle relaxant reversal drugs. Then the investigators will record PSI and EMG parameters when TOF is %0, %25, %50,%75,%90. When TOF is %90 the investigators will extubate the patient. The investigators will record PSI and EMG parameters after 5 minutes.

Read the detailed description

The study is planned prospective and observational. The study started after approval of Erzincan Binali Yıldırım University Ethics Committee and taking written approval of patients. The study includes 84 patients who has surgery continues more then 1 hour, who is between ages 18-65, who is ASA I,II and III. The patients who has allergical reactions of the drugs used, neurological or neuromuscular diseases,the patients who use drugs effecting the neuromuscular junction, pregnant patients, electrolyte disregulations, major organ failures, liver failure, kidney failure, obese and cachectic patients are excluded from the study.

All patients will be informed and signed written approval 1 day before the surgery. Patients will be taken to the operating room, venous catheter will be applied on antecubital area. 3 channel EKG , SpO2 Monitor and noninvasive blood pressure monitorisation will be applied. The patients will be taken 2-4 litres of O2 with nasal cannula .The Train Of Four (TOF) Monitor will be placed on ulnar nerve on right wrist of the patients who has surgery under general anaesthesia. This is for stimulation of adductor pollicis muscle. Sedline (Masimo Electromyography(EMG) and Patient State Index(PSI)) Monitor will be placed on the frontal area of head. After the induction of general anaesthesia the investigators will wait for disappearance of eyelash reflex. TOF monitor will be calibrated and muscle relaxant will be applied. After TOF is %0 and disappearance of thumb movement the patient will be intubated. After surgery the investigators will apply muscle relaxant reversal drugs. PSI and EMG parameters will be recorded when TOF is %0, %25, %50,%75,%90. When TOF is %90 the investigators will extubate the patient. PSI and EMG parameters will be recorded after 5 minutes. The patient will be taken to the PACU room. On 5,10,30 minutes after surgery, the investigators will record aldrete score of patients.

02

Conditions studied

  • Muscle Relaxation
03

In context

Lead sponsor

Erzincan University is the lead sponsor of 42 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

the patients wha has surgery continues more then 1 hour

Inclusion criteria

  • surgery continues more then 1 hour
  • between ages 18-65
  • ASA I,II and III patients

Exclusion criteria

Exclusion Criteria:

  • The patients who has allergical reactions of the drugs used
  • neurological or neuromuscular diseases
  • the patients who use drugs effecting the neuromuscular junction
  • pregnant patients
  • electrolyte disregulations
  • major organ failures, liver failure, kidney failure
  • obese and cachectic patients
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • DeviceMasimo Sedline Monitor Patient State Index

    Masimo Sedline Monitor shows frontal electromyography and patient state index, Train of four monitor shows muscle strength on adductor pollicis muscle

    Also known as: Train Of Four

06

What researchers measure

Primary outcomes

  1. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 0 minutes

  2. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 1 minutes

  3. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 2 minutes

  4. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 3 minutes

  5. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 4 minutes

  6. Patient State Index

    Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs

    Time frame: 5 minutes

  7. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 0 minutes

  8. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 1 minutes

  9. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 2 minutes

  10. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 3 minutes

  11. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 4 minutes

  12. Electromyography (Frontal EMG)

    Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs

    Time frame: 5 minutes

07

Study locations

1 site
  • Erzincan University
    Erzincan, Merkez 24000, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03926650
Lead sponsor
Erzincan University
Responsible party
Hakan Gokalp TAS (Research Assistant Doctor Hakan Gökalp TAŞ, Erzincan University) — Principal investigator
First posted
Apr 24, 2019
Start date
Mar 1, 2019
Primary completion
Mar 1, 2020
Completion
Aug 1, 2020
Last update
Apr 9, 2021

Study contacts

Hakan G. Taş
principal investigator · Mengucek Gazi Education and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion